Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report

Sacubitril/valsartan has been shown to reduce cardiovascular mortality and hospitalizations in patients with HFrEF when compared to enalapril. There are also some evidences of its potential antiarrhythmic effects. We present a report where we found a relation between reverse ventricular remodeling a...

Descripción completa

Detalles Bibliográficos
Autores principales: Corrado, Egle, Saladino, Antonino, Morgante, Giusy, Mignano, Antonino, Nugara, Cinzia, Novo, Giuseppina, Coppola, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455401/
https://www.ncbi.nlm.nih.gov/pubmed/32884751
http://dx.doi.org/10.1002/ccr3.2655
_version_ 1783575616718635008
author Corrado, Egle
Saladino, Antonino
Morgante, Giusy
Mignano, Antonino
Nugara, Cinzia
Novo, Giuseppina
Coppola, Giuseppe
author_facet Corrado, Egle
Saladino, Antonino
Morgante, Giusy
Mignano, Antonino
Nugara, Cinzia
Novo, Giuseppina
Coppola, Giuseppe
author_sort Corrado, Egle
collection PubMed
description Sacubitril/valsartan has been shown to reduce cardiovascular mortality and hospitalizations in patients with HFrEF when compared to enalapril. There are also some evidences of its potential antiarrhythmic effects. We present a report where we found a relation between reverse ventricular remodeling and arrhythmic reduction in a patient treated with sacubitril/valsartan.
format Online
Article
Text
id pubmed-7455401
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74554012020-09-02 Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report Corrado, Egle Saladino, Antonino Morgante, Giusy Mignano, Antonino Nugara, Cinzia Novo, Giuseppina Coppola, Giuseppe Clin Case Rep Case Reports Sacubitril/valsartan has been shown to reduce cardiovascular mortality and hospitalizations in patients with HFrEF when compared to enalapril. There are also some evidences of its potential antiarrhythmic effects. We present a report where we found a relation between reverse ventricular remodeling and arrhythmic reduction in a patient treated with sacubitril/valsartan. John Wiley and Sons Inc. 2020-06-09 /pmc/articles/PMC7455401/ /pubmed/32884751 http://dx.doi.org/10.1002/ccr3.2655 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Corrado, Egle
Saladino, Antonino
Morgante, Giusy
Mignano, Antonino
Nugara, Cinzia
Novo, Giuseppina
Coppola, Giuseppe
Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
title Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
title_full Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
title_fullStr Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
title_full_unstemmed Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
title_short Reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: Case report
title_sort reverse remodeling and arrhythmic burden reduction in a patient with an implantable cardioverter defibrillator treated with sacubitril/valsartan: case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455401/
https://www.ncbi.nlm.nih.gov/pubmed/32884751
http://dx.doi.org/10.1002/ccr3.2655
work_keys_str_mv AT corradoegle reverseremodelingandarrhythmicburdenreductioninapatientwithanimplantablecardioverterdefibrillatortreatedwithsacubitrilvalsartancasereport
AT saladinoantonino reverseremodelingandarrhythmicburdenreductioninapatientwithanimplantablecardioverterdefibrillatortreatedwithsacubitrilvalsartancasereport
AT morgantegiusy reverseremodelingandarrhythmicburdenreductioninapatientwithanimplantablecardioverterdefibrillatortreatedwithsacubitrilvalsartancasereport
AT mignanoantonino reverseremodelingandarrhythmicburdenreductioninapatientwithanimplantablecardioverterdefibrillatortreatedwithsacubitrilvalsartancasereport
AT nugaracinzia reverseremodelingandarrhythmicburdenreductioninapatientwithanimplantablecardioverterdefibrillatortreatedwithsacubitrilvalsartancasereport
AT novogiuseppina reverseremodelingandarrhythmicburdenreductioninapatientwithanimplantablecardioverterdefibrillatortreatedwithsacubitrilvalsartancasereport
AT coppolagiuseppe reverseremodelingandarrhythmicburdenreductioninapatientwithanimplantablecardioverterdefibrillatortreatedwithsacubitrilvalsartancasereport

Ejemplares similares